| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | 96.2B +17.9% | 81.6B +19.8% | 68.1B +19.5% | 57.0B +22.0% | 46.7B |
| Cost of Revenue | 24.1B +17.7% | 20.5B +20.1% | 17.0B +12.4% | 15.2B +17.6% | 12.9B |
| Gross Profit | 72.1B +18.0% | 61.2B +19.7% | 51.1B +22.1% | 41.8B +23.6% | 33.9B |
| Operating Expenses | 8.4B +10.3% | 7.6B +12.2% | 6.8B +16.4% | 5.8B +7.9% | 5.4B |
| R&D | 7.1B +11.6% | 6.3B +14.7% | 5.5B +17.2% | 4.7B +9.6% | 4.3B |
| SG&A | 1.4B +4.2% | 1.3B +1.4% | 1.3B +13.1% | 1.1B +1.1% | 1.1B |
| Operating Income | 63.7B +19.0% | 53.5B +20.9% | 44.3B +23.0% | 36.0B +26.6% | 28.4B |
| EBITDA | 64.9B +18.9% | 54.5B +20.9% | 45.1B +22.7% | 36.8B +26.3% | 29.1B |
| Net Income | 59.7B +2.3% | 58.3B +35.8% | 43.0B +34.6% | 31.9B +20.8% | 26.4B |
| EPS (Basic) | $2.47 +2.9% | $2.40 +35.6% | $1.77 +35.1% | $1.31 +21.3% | $1.08 |
| EPS (Diluted) | $2.46 +2.9% | $2.39 +35.8% | $1.76 +35.4% | $1.30 +20.4% | $1.08 |
| Shares (Diluted) | 24.3B -0.4% | 24.4B -0.2% | 24.4B -0.2% | 24.5B -0.2% | 24.5B |